ANDA 70828, held by Sandoz. Doxepin Hydrochloride.
As of Nov 16, 2026, ANDA 70828 (Doxepin Hydrochloride), held by Sandoz, was first approved by FDA on May 15, 1986, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 15, 1986 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Doxepin HydrochlorideEQ 50MG BASE · capsule;oral | Doxepin Hydrochloride | Discontinued |
| Jul 17, 2014 | Supplement 14Labeling · Standard review | Approved | None posted |
| May 9, 2001 | Supplement 10Manufacturing | Approved | None posted |
| Mar 13, 1995 | Supplement 6Labeling | Approved | None posted |
| Mar 1, 1995 | Supplement 5Manufacturing | Approved | None posted |
| Aug 19, 1993 | Supplement 4Labeling | Approved | None posted |
| May 1, 1991 | Supplement 3Manufacturing | Approved | None posted |
| Jan 17, 1989 | Supplement 2Labeling | Approved | None posted |
| May 15, 1986 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters